Altamira Therapeutics to Host First Half 2023 Financial Results and Business Update Call on September 12th
HAMILTON, BERMUDA , Sept. 06, 2023 (GLOBE NEWSWIRE) — Altamira Therapeutics Ltd. (“Altamira” or the…
HAMILTON, BERMUDA , Sept. 06, 2023 (GLOBE NEWSWIRE) — Altamira Therapeutics Ltd. (“Altamira” or the…
– Lead program, GT-2108 for the treatment of moderate-to-severe ulcerative colitis advancing toward completion of…
– Lead program, GT-2108 for the treatment of moderate-to-severe ulcerative colitis advancing toward completion of…
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
WALTHAM, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a…
WALTHAM, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a…
TORONTO and HAIFA, Israel, Sept. 06, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX)…
TORONTO and HAIFA, Israel, Sept. 06, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX)…
FARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE: ENZ) announced today…
FARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE: ENZ) announced today…
– Kriya envisions treating people with NASH using a one-time intramuscular gene therapy enabling continuous…
– Kriya envisions treating people with NASH using a one-time intramuscular gene therapy enabling continuous…
CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
The Upgrade Provides Significant Enhancements to the Popular Product’s Features and Functionality OCOEE, FL, Sept….